← Eichor
Condition: Active Psoriatic Arthritis Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Active Psoriatic Arthritis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Clinical Trial of TQH3906 Capsules in the Treatment of Active Psoriatic Arthritis
Phase 2 · 44 location(s) · Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharm · NCT07406035Korea Xeljanz Post-marketing Surveillance for Juvenile Idiopathic Arthritis
Phase N/A · 1 location(s) · Pfizer · NCT05754710A Study of the Efficacy and Safety of SHR-1314 for Adult Active Psoriatic Arthritis
Phase 3 · 1 location(s) · Suzhou Suncadia Biopharmaceuticals Co., Ltd. · NCT06640257Korean Post-marketing Surveillance for Xeljanz XR
Phase N/A · 1 location(s) · Pfizer · NCT04876781REDO-JAK: Dose Reduction of Janus Kinase Inhibitors in Patients With Inflammatory Rheumatic Diseases
Phase 4 · 7 location(s) · Sint Maartenskliniek · NCT07160231Transcutaneous Auricular Vagus Nerve Stimulation in Psoriatic Arthritis
NA · 1 location(s) · Marmara University · NCT07653009Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis
Phase 3 · 16 location(s) · Takeda · NCT07286058A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With J
Phase 3 · 33 location(s) · AbbVie · NCT06100744A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psori
Phase 4 · 55 location(s) · Eli Lilly and Company · NCT06864026A Phase II Study to Evaluate the Efficacy and Safety of D-2570 in Subjects With Active Psoriatic Arthritis
Phase 2 · 1 location(s) · InventisBio Co., Ltd · NCT07315061A Study of Picankibart in Patients With Active Psoriatic Arthritis
Phase 2/Phase 3 · 1 location(s) · Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD. · NCT07295509A Study to Evaluate the Efficacy and Safety of JNJ-88545223 for the Treatment of Participants With Active Psoriatic Arth
Phase 2 · 72 location(s) · Janssen Research & Development, LLC · NCT07321873A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced and Biologic-naive Par
Phase 3 · 224 location(s) · Janssen Research & Development, LLC · NCT06807424A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
Phase 3 · 188 location(s) · Takeda · NCT06671483COMFI - a COMbined Fatigue Intervention
NA · 2 location(s) · The Danish Center for Expertise in Rheumatology · NCT06666452Apremilast Pediatric Study in Children With Active Juvenile Psoriatic Arthritis
Phase 3 · 45 location(s) · Amgen · NCT04804553Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response
Phase 3 · 139 location(s) · MoonLake Immunotherapeutics AG · NCT06641089A Study to Evaluate the Drug Levels, Efficacy, and Safety of Deucravacitinib (BMS-986165) in Pediatric Participants With
Phase 3 · 47 location(s) · Bristol-Myers Squibb · NCT06869551Prospective Study of Classification and Activity Assessment of Psoriatic Arthritis Based on Power Doppler (PD) Ultrasono
Phase N/A · 2 location(s) · Nanjing Medical University · NCT06730334Influence of Sodium Intake in spondyLoarthriTes
NA · 4 location(s) · Centre Hospitalier Universitaire de Besancon · NCT06259890A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adu
Phase 1 · 63 location(s) · UCB Biopharma SRL · NCT07290036Active Pharmacovigilance Study of the Medicine Rinvoq™ (Upadacitinib)
Phase N/A · 3 location(s) · Universidade do Porto · NCT06498167A Study to Evaluate the Impact of Upadacitinib on Spondyloarthritis Outcomes in Patients With Active Psoriatic Arthritis
Phase 4 · 5 location(s) · CARE ARTHRITIS LTD. · NCT06454188An Open-label Study to Evaluate the Pharmacokinetics and Safety of Bimekizumab in Pediatric Study Participants With Acti
Phase 3 · 23 location(s) · UCB Biopharma SRL · NCT06668181Efficacy and Safety of HS-10374 Compared to Placebo in Adults With Active Psoriatic Arthritis
Phase 2 · 1 location(s) · Hansoh BioMedical R&D Company · NCT06176508A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines
Phase 3 · 122 location(s) · Takeda · NCT06671496Study of Targeted Therapies for the Treatment of Adult Participants With Active Psoriatic Arthritis
Phase 2 · 37 location(s) · AbbVie · NCT06865105
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.